IL2 and cancer: They can destroy the tumor vasculature, induce cellular senescence of cancer cells, and help CD8+ T cells in the effector phase, a role mostly associated with T-helper (Th)1 responses mediated by IL-2 and IFN-γ producing CD4+ T cells (69).